share_log

B of A Securities Initiates Coverage On Madrigal Pharmaceuticals With Underperform Rating, Announces Price Target of $150

Moomoo 24/7 ·  Apr 22 06:19

B of A Securities analyst Alexandria Hammond initiates coverage on Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Underperform rating and announces Price Target of $150.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment